.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Autoimmune encephalitis (AE) presents a significant challenge in clinical neurology due to its complex immune-mediated pathology. Doctors often struggle with refractory cases that do not respond to standard therapies. However, recent research into efgartigimod autoimmune encephalitis treatment suggests a new path forward. This innovative human IgG Fc receptor antagonist specifically targets and clears pathogenic IgG autoantibodies. By blocking the neonatal Fc receptor (FcRn), efgartigimod effectively reduces circulating antibody levels. This process may lead to rapid symptom relief for patients.
Researchers retrospectively analyzed data from 15 patients diagnosed with AE who underwent treatment with efgartigimod. The team focused on the modified Rankin Scale (mRS) and Clinical Assessment Scale for Autoimmune Encephalitis (CASE) scores. After a four-week treatment cycle, the results were highly encouraging. The median mRS scores dropped from 4 to 2, indicating a substantial recovery of function. Furthermore, CASE scores showed a dramatic decrease from a median of 13 down to 2. These improvements reflect clinically meaningful changes in patient disability and symptom severity.
Additionally, the study monitored routine laboratory data and immunological parameters. The results showed that efgartigimod is safe and well-tolerated. No significant adverse events occurred during the observation period. Consequently, these findings support the potential of FcRn inhibitors as a fast-acting add-on therapy for antibody-mediated brain inflammation. Medical professionals might find this particularly useful for patients who fail to respond to first-line corticosteroids or plasma exchange.
Efgartigimod acts as a neonatal Fc receptor (FcRn) antagonist. It outcompetes endogenous IgG for binding to FcRn, which leads to the rapid degradation of pathogenic autoantibodies rather than their recycling back into the bloodstream.
The study observed significant improvements in both the modified Rankin Scale (mRS) and the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) scores within four weeks of initiating treatment.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Qin J et al. The Clinical Efficacy and Safety of Efgartigimod in the Treatment of Autoimmune Encephalitis. Immunol Invest. 2026 May 20. doi: 10.1080/08820139.2026.2665257. PMID: 42159021.
2. Zhang Y, et al. Rapid symptom relief in autoimmune encephalitis with efgartigimod: a three-patient case series. Front Immunol. 2024 Oct 3. doi: 10.3389/fimmu.2024.1485231.
3. argenx. Mechanism of Action: Efgartigimod (Vyvgart). 2025.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study reveals that efgartigimod significantly improves clinical scores and clears pathogenic IgG in patients with autoimmune encephalitis....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
